SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000732485-04-000052
Filing Date
2004-11-29
Accepted
2004-11-29 10:35:38
Documents
1
Period of Report
2004-11-24

Document Format Files

Seq Description Document Type Size
1 wir159.html 4  
1 wir159.xml 4 4771
  Complete submission text file 0000732485-04-000052.txt   6747
Mailing Address ONE KENDALL SQUARE CAMBRIDGE MA 02139
Business Address ONE KENDALL SQ CAMBRIDGE MA 02139 6172527500
GENZYME CORP (Issuer) CIK: 0000732485 (see all company filings)

IRS No.: 061047163 | State of Incorp.: MA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address ONE KENDALL SQUARE CAMBRIDGE MA 02139
Business Address C/O GENZYME CORP ONE KENDALL SQ CAMBRIDGE MA 02139 6172527500
WIRTH PETER (Reporting) CIK: 0001021041 (see all company filings)

State of Incorp.: MA | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-14680 | Film No.: 041169858
SIC: 2836 Biological Products, (No Diagnostic Substances)